Michael Dixon, Ph.D.

Michael Dixon

LinkedIn LogoPresident & CEO
(402) 559-2468

Michael Dixon is President and CEO, working with faculty, students and staff to help commercialize innovative, new ideas that have the potential to improve public health in Nebraska and beyond. Dr. Dixon is responsible for setting UNeMed’s strategic path while directing efforts to protect, market and license new technologies.

Dr. Dixon is a graduate of Leadership Omaha Class 32 and a 2011 recipient of the Midlands Business Journal “40 under 40” award. As an active member of the community, Dr. Dixon serves on several Boards of Directors, including Invest Nebraska Corporation, a non-profit, venture development organization that advises and invests in companies and early stage business ideas in Nebraska. He also sits on the board of Bio Nebraska, a nonprofit trade association dedicated to the development and growth of Nebraska’s bioscience industry.

Dr. Dixon holds a doctorate in Pathology and Microbiology from UNMC.

Recent UNeMed news featuring Dr. Dixon:

University of Nebraska ranks among world’s top 100 in earning U.S. patents

OMAHA & LINCOLN, Nebraska (June 24, 2020)—For the third straight year, the University of Nebraska system is ranked among the top 100 academic institutions worldwide in earning U.S. patents. A newly released report from the National Academy of Inventors and Intellectual Property Owners Association lists the NU system at No. 65, a 14-spot improvement from …

UNeMed lands prototyping grant to build medical device pipeline

OMAHA, Neb. (June 10, 2020)—UNeMed recently secured a $50,000 SHARPhub grant to create the Medical Device Prototype Pipeline project. UNeMed—the technology transfer and commercialization office for the Omaha campuses of the University of Nebraska—will identify projects with potential as healthcare products that can form the basis of a startup company. UNeMed will then work with …

New intubation shield protects healthcare workers from coronavirus during intubation procedures 

OMAHA, Neb. (April 7, 2020)—A new protective barrier invented at the University of Nebraska Medical Center shields and protects healthcare workers from contagions and other contaminants during intubation procedures. Inventors Thomas Schulte, MD, and Michael Ash, MD, in collaboration with Scott Nepper at Design Plastics, Inc. in Omaha—developed the device in response to the COVID-19 …

Date set, registration open for 2020 MidWest Drug Development Conference

Two-day event returns on Oct. 5-6 OMAHA, Nebraska (January 6, 2020)—Due the continued success and popularity of the MidWest Drug Development Conference, the event will return for a third year and registrations are now open, planners announced today. The conference will again span two days, featuring Midwestern university technologies, beginning on Monday, Oct. 5, and …

The year in review: Highlights from 2019

It’s time again to look back at the last calendar year, review highlights and reflect on some of the more important stories, developments and most popular posts from 2019. 1. Innovation Week Innovation Week continues its reign as the most well-traveled sector of the UNeMed website. Innovation Week is an annual showcase for all UNMC …

Michael Dixon

UNeMed will be featured in halftime radio show

LINCOLN, Nebraska (Nov. 15, 2019)—UNeMed President and CEO, Michael Dixon, Ph.D., will be the featured guest during the University of Nebraska President’s Halftime Show of the Cornhuskers’ football game with the No. 14 Wisconsin Badgers on Saturday. The game kickoffs in Lincoln at 11 a.m., and the radio broadcast will be carried on the Husker …

Comments are closed.